Researchers have developed a new approach that can learn how to train itself and learn new things and outperform the current machine learning systems of drug discovery and design, which in turn could accelerate the search for new disease treatments. This method is called transformational ML or machine learning. It was developed by a team of scientists and researchers from the UK, Sweden, India, and the Netherlands. Through this method, the machines can learn from multiple problems and improve their performance. In recent years, artificial intelligence has transformed medical research by revealing data patterns that can be used to predict new diseases and treatment outcomes for individual patients.

Sepsis claims the lives of nearly 270,000 people in the U.S. each year. The unpredictable medical condition can progress rapidly, leading to a swift drop in blood pressure, tissue damage, multiple organ failure, and death. Prompt interventions by medical professionals save lives, but some sepsis treatments can also contribute to a patient's deterioration, so choosing the optimal therapy can be a difficult task. For instance, in the early hours of severe sepsis, administering too much fluid intravenously can increase a patient's risk of death. To help clinicians avoid remedies that may potentially contribute to a patient's death, researchers at MIT and elsewhere have developed a machine-learning model that could be used to identify treatments that pose a higher risk than other options.

Sepsis is a potentially life-threatening condition, occurs when your body has an unusually severe response to an infection. Some sepsis treatments lead to a patient's deterioration. Hence, selecting the optimal therapy is a challenging task. In recent years, Machine learning has successfully framed many sequential decision-making problems. Scientists at MIT and elsewhere do the same.